The Wearable Cardioverter-Defibrillator Is It Now the Standard of Care?

被引：3
|
作者：
Lee, Byron K. [1 ]
Olgin, Jeffrey E. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Med, Div Cardiol, 500 Parnassus Ave,Box 1354, San Francisco, CA 94143 USA
来源：
CIRCULATION | 2016年 / 134卷 / 09期
关键词：
Editorials; LEFT-VENTRICULAR DYSFUNCTION; MYOCARDIAL-INFARCTION; HEART-DISEASE; HIGH-RISK; REVASCULARIZATION; CARDIOMYOPATHY; PREVENTION; MORTALITY; TRIAL; DEATH;
D O I：
10.1161/CIRCULATIONAHA.116.024287
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：644 / 646
页数：3
相关论文
共 50 条
  • [31] Right Ventricular Dysfunction and the Incidence of Implantable Cardioverter-Defibrillator Therapies
    Aktas, Mehmet K.
    Kim, David D.
    McNitt, Scott
    Huang, David T.
    Rosero, Spencer Z.
    Hall, Burr W.
    Zareba, Wojciech
    Daubert, James P.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 (12): : 1501 - 1508
  • [32] A novel artificial intelligence based algorithm to reduce wearable cardioverter-defibrillator alarms
    Arkles, Jeffrey
    Delaughter, Craig
    D'Souza, Benjamin
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2023, 66 (07) : 1723 - 1728
  • [33] Survival After Implantable Cardioverter-Defibrillator Shocks
    Aktas, Mehmet K.
    Younis, Arwa
    Zareba, Wojciech
    Kutyifa, Valentina
    Klein, Helmut
    Daubert, James P.
    Estes, Mark
    McNitt, Scott
    Polonsky, Bronislava
    Goldenberg, Ilan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (20) : 2453 - 2462
  • [34] Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis
    Masri, Ahmad
    Altibi, Ahmed M.
    Erqou, Sebhat
    Zmaili, Mohammad A.
    Saleh, Ala
    Al-Adham, Raed
    Ayoub, Karam
    Baghal, Moaaz
    Alkukhun, Laith
    Barakat, Amr F.
    Jain, Sandeep
    Saba, Samir
    Adelstein, Evan
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (02) : 152 - 161
  • [35] Wearable Cardioverter-Defibrillator Use in Patients Perceived to Be at High Risk Early Post-Myocardial Infarction
    Epstein, Andrew E.
    Abraham, William T.
    Bianco, Nicole R.
    Kern, Karl B.
    Mirro, Michael
    Rao, Sunil V.
    Rhee, Edward K.
    Solomon, Scott D.
    Szymkiewicz, Steven J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (21) : 2000 - 2007
  • [36] Evaluation of patients with implantable cardioverter-defibrillator in a Latin American tertiary center
    Franca, Anna Terra
    Martins, Larissa Natany Almeida
    de Oliveira, Derick Matheus
    de Castilho, Fabio Morato
    Branco, Beatriz Castello
    Wilnes, Bruno
    Ribeiro, Antonio Luiz P.
    do Carmo, Andre Assis Lopes
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2024, 35 (04) : 675 - 684
  • [37] The wearable cardioverter-defibrillator is needed for most high-risk patients
    Lee, Byron K.
    HEART RHYTHM O2, 2020, 1 (03): : 227 - 229
  • [38] Use of the Wearable Cardioverter Defibrillator in High-Risk Populations
    Lamichhane, Madhab
    Safadi, Abdul
    Surapaneni, Phani
    Salehi, Negar
    Thakur, Ranjan K.
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (08)
  • [39] Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator
    Manovel-Sanchez, Ana J.
    Pedrote-Martinez, Alonso
    Arana-Rueda, Eduardo
    de Tejada, Francisco Errazquin-Saenz
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (07): : 784 - 784
  • [40] Shouldn't Everyone Have an Implantable Cardioverter-Defibrillator?
    Passman, Rod
    Kadish, Alan
    CIRCULATION, 2009, 120 (22) : 2166 - 2167
12345